Ayal Ronen of the FreeMind Group gave a demonstration of a new shared work space we have developed and how it is propelling grant writing into the digital age.

View Slide Deck

Dr. Charles Cywin of the National Institute of Neurological Disorders and Stroke spoke about the programs available to support neuroscience translational research.

View Slide Deck

Dr. Matthew Portnoy of the National Institutes of Health gave updates on the Small Business Innovation Research and Small Business Technology Transfer Programs.

View Slide Deck

Dennis Ford of Life Science Nation shared tips on interacting with investors as you work on a strategic method of fundraising for your R&D.

View Slide Deck

John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.


Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

Dr. Natalie Wisniewski, of Profusa, Inc., gave some insight about her company’s non-dilutive funding journey, starting with their initial grant from DARPA in 2011 through to today.


Dr. James B. Phillips of USAMRMC, Department of Defense, shared with the audience the mission of the US Army Medical Research and Material Command and the Medical Technology Enterprise Consortium, discussing opportunities available for partnering and engaging with Industry.

View Slide Deck

Ram May-Ron, Managing Partner of the FreeMind Group, opened the 13th Annual Non-Dilutive Funding Summit with a few comments on the value of non-dilutive funding to the life sciences industry.

Ram May-Ron of the FreeMind Group opens the 12th Annual Non-Dilutive Funding Summit with a few remarks on recent trends in life science R&D funding and the importance of federal grants as a strategic source of funds.